Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation. 1978;58(6):1204–11. https://doi.org/10.1161/01.cir.58.6.1204.

Article  CAS  PubMed  Google Scholar 

Cheong BY, Muthupillai R, Nemeth M, et al. The utility of delayed-enhancement magnetic resonance imaging for identifying nonischemic myocardial fibrosis in asymptomatic patients with biopsy-proven systemic sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2009;26(1):39–46.

CAS  PubMed  Google Scholar 

Birnie DH, Sauer WH, Bogun F, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014;11(7):1305–23. https://doi.org/10.1016/j.hrthm.2014.03.043.

Article  PubMed  Google Scholar 

Yafasova A, Fosbøl EL, Schou M, et al. Long-term adverse cardiac outcomes in patients with sarcoidosis. J Am Coll Cardiol. 2020;76(7):767–77. https://doi.org/10.1016/j.jacc.2020.06.038.

Article  PubMed  Google Scholar 

Schuller JL, Zipse M, Crawford T, et al. Implantable cardioverter defibrillator therapy in patients with cardiac sarcoidosis. J Cardiovasc Electrophysiol. 2012;23(9):925–9. https://doi.org/10.1111/j.1540-8167.2012.02350.x.

Article  PubMed  Google Scholar 

Kandolin R, Lehtonen J, Airaksinen J, et al. Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study. Circulation. 2015;131(7):624–32. https://doi.org/10.1161/CIRCULATIONAHA.114.011522.

Article  PubMed  Google Scholar 

Lagana SM, Parwani AV, Nichols LC. Cardiac sarcoidosis: a pathology-focused review. Arch Pathol Lab Med. 2010;134(7):1039–46. https://doi.org/10.5858/2009-0274-RA.1.

Article  PubMed  Google Scholar 

Kato Y, Morimoto S, Uemura A, Hiramitsu S, Ito T, Hishida H. Efficacy of corticosteroids in sarcoidosis presenting with atrioventricular block. Sarcoidosis Vasc Diffuse Lung Dis. 2003;20(2):133–7.

PubMed  Google Scholar 

Fazelpour S, Sadek MM, Nery PB, et al. Corticosteroid and immunosuppressant therapy for cardiac sarcoidosis: a systematic review. J Am Heart Assoc. 2021;10(17):e021183. https://doi.org/10.1161/JAHA.121.021183.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yodogawa K, Seino Y, Ohara T, Takayama H, Katoh T, Mizuno K. Effect of corticosteroid therapy on ventricular arrhythmias in patients with cardiac sarcoidosis. Ann Noninvasive Electrocardiol. 2011;16(2):140–7. https://doi.org/10.1111/j.1542-474X.2011.00418.x.

Article  PubMed  PubMed Central  Google Scholar 

Okada DR, Bravo PE, Vita T, et al. Isolated cardiac sarcoidosis: A focused review of an under-recognized entity. J Nucl Cardiol. 2018;25(4):1136–46. https://doi.org/10.1007/s12350-016-0658-1.

Article  PubMed  Google Scholar 

Kebed KY, Carter SV, Flatley E, et al. Prevalence of newly diagnosed sarcoidosis in patients with ventricular arrhythmias: a cardiac magnetic resonance and 18F-FDG cardiac PET study. Int J Cardiovasc Imaging. 2021;37(4):1361–9. https://doi.org/10.1007/s10554-020-02090-2.

Article  PubMed  Google Scholar 

Uemura A, Morimoto S, Hiramitsu S, Kato Y, Ito T, Hishida H. Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies. Am Heart J. 1999;138(2 Pt 1):299–302. https://doi.org/10.1016/s0002-8703(99)70115-8.

Article  CAS  PubMed  Google Scholar 

Patel AR, Klein MR, Chandra S, et al. Myocardial damage in patients with sarcoidosis and preserved left ventricular systolic function: an observational study. Eur J Heart Fail. 2011;13(11):1231–7. https://doi.org/10.1093/eurjhf/hfr099.

Article  PubMed  PubMed Central  Google Scholar 

Okasha O, Kazmirczak F, Chen KA, Farzaneh-Far A, Shenoy C. Myocardial involvement in patients with histologically diagnosed cardiac sarcoidosis: a systematic review and meta-analysis of gross pathological images from autopsy or cardiac transplantation cases. J Am Heart Assoc. 2019;8(10):e011253. https://doi.org/10.1161/JAHA.118.011253.

Article  PubMed  PubMed Central  Google Scholar 

• Kuo L, Han Y, Mui D, et al. Diagnostic specificity of basal inferoseptal triangular late gadolinium enhancement for identification of cardiac sarcoidosis. JACC Cardiovasc Imaging. 2019;12(12):2574–6. https://doi.org/10.1016/j.jcmg.2019.06.024. This paper assessed the prevalence of various late gadolinium enhancement patterns in cardiac sarcoidosis. This study demonstrated the high specificity of triangular pattern of LGE (‟triangle sign”) for cardiac sarcoidosis.

Article  PubMed  Google Scholar 

Puntmann VO, Isted A, Hinojar R, Foote L, Carr-White G, Nagel E. T1 and T2 mapping in recognition of early cardiac involvement in systemic sarcoidosis. Radiology. 2017;285(1):63–72. https://doi.org/10.1148/radiol.2017162732.

Article  PubMed  Google Scholar 

Tonegawa-Kuji R, Oyama-Manabe N, Aoki R, et al. T2-weighted short-tau-inversion-recovery imaging reflects disease activity of cardiac sarcoidosis. Open Heart. 2021;8(2). https://doi.org/10.1136/openhrt-2021-001728.

Crouser ED, Ono C, Tran T, He X, Raman SV. Improved detection of cardiac sarcoidosis using magnetic resonance with myocardial T2 mapping. Am J Respir Crit Care Med. 2014;189(1):109–12. https://doi.org/10.1164/rccm.201309-1668LE.

Article  PubMed  PubMed Central  Google Scholar 

Smedema JP, Snoep G, van Kroonenburgh MP, et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol. 2005;45(10):1683–90. https://doi.org/10.1016/j.jacc.2005.01.047.

Article  PubMed  Google Scholar 

Velangi PS, Chen KA, Kazmirczak F, et al. Right ventricular abnormalities on cardiovascular magnetic resonance imaging in patients with sarcoidosis. JACC Cardiovasc Imaging. 2020;13(6):1395–405. https://doi.org/10.1016/j.jcmg.2019.12.011.

Article  PubMed  PubMed Central  Google Scholar 

Coleman GC, Shaw PW, Balfour PC, et al. Prognostic value of myocardial scarring on cmr in patients with cardiac sarcoidosis. JACC Cardiovasc Imaging. 2017;10(4):411–20. https://doi.org/10.1016/j.jcmg.2016.05.009.

Article  PubMed  Google Scholar 

Murtagh G, Laffin LJ, Beshai JF, et al. Prognosis of myocardial damage in sarcoidosis patients with preserved left ventricular ejection fraction: risk stratification using cardiovascular magnetic resonance. Circ Cardiovasc Imaging. 2016;9(1):e003738. https://doi.org/10.1161/CIRCIMAGING.115.003738.

Article  PubMed  PubMed Central  Google Scholar 

Patel MR, Cawley PJ, Heitner JF, et al. Detection of myocardial damage in patients with sarcoidosis. Circulation. 2009;120(20):1969–77. https://doi.org/10.1161/CIRCULATIONAHA.109.851352.

Article  PubMed  PubMed Central  Google Scholar 

Crawford T, Mueller G, Sarsam S, et al. Magnetic resonance imaging for identifying patients with cardiac sarcoidosis and preserved or mildly reduced left ventricular function at risk of ventricular arrhythmias. Circ Arrhythm Electrophysiol. 2014;7(6):1109–15. https://doi.org/10.1161/CIRCEP.113.000156.

Article  PubMed  Google Scholar 

Nabeta T, Kitai T, Naruse Y, et al. Risk stratification of patients with cardiac sarcoidosis: the ILLUMINATE-CS registry. Eur Heart J. 2022. https://doi.org/10.1093/eurheartj/ehac323.

Article  PubMed  Google Scholar 

Greulich S, Deluigi CC, Gloekler S, et al. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis. JACC Cardiovasc Imaging. 2013;6(4):501–11. https://doi.org/10.1016/j.jcmg.2012.10.021.

Article  PubMed  Google Scholar 

• Athwal PSS, Chhikara S, Ismail MF, et al. Cardiovascular magnetic resonance imaging phenotypes and long-term outcomes in patients with suspected cardiac sarcoidosis. JAMA Cardiol. 2022. https://doi.org/10.1001/jamacardio.2022.2981. This paper assessed the prognostic significance of ‟pathology-frequent” late gadolinium enhancement patterns—defined as LGE patterns commonly identified on gross pathology—in cardiac sarcoidosis. They found that pathology-frequent LGE was associated with arrhythmic events in cardiac sarcoidosis irrespective of left ventricular ejection fraction.

Article  PubMed  Google Scholar 

Smedema JP, van Geuns RJ, Ector J, Heidbuchel H, Ainslie G, Crijns HJGM. Right ventricular involvement and the extent of left ventricular enhancement with magnetic resonance predict adverse outcome in pulmonary sarcoidosis. ESC Heart Fail. 2018;5(1):157–71. https://doi.org/10.1002/ehf2.12201.

Article  PubMed  Google Scholar 

• Gowani Z, Habibi M, Okada DR, et al. Utility of cardiac magnetic resonance imaging versus cardiac positron emission tomography for risk stratification for ventricular arrhythmias in patients with cardiac sarcoidosis. Am J Cardiol. 2020;134:123–9. https://doi.org/10.1016/j.amjcard.2020.08.007. This study assessed the prognostic value of CMR-derived LGE versus inflammation on myocardial PET for prediction of arrhythmic events in CS. They found that the risk of arrhythmic events was high in those with LGE irrespective of the presence of inflammation on PET. Conversely, event rates were reassuredly low in those with inflammation on PET who did not have LGE on CMR.

Article  PubMed  Google Scholar 

Muser D, Santangeli P, Liang JJ, et al. Characterization of the electroanatomic substrate in cardiac sarcoidosis: correlation with imaging findings of scar and inflammation. JACC Clin Electrophysiol. 2018;4(3):291–303. https://doi.org/10.1016/j.jacep.2017.09.175.

Article  PubMed  Google Scholar 

Kaur D, Roukoz H, Shah M, et al. Impact of the inflammation on the outcomes of catheter ablation of drug-refractory ventricular tachycardia in cardiac sarcoidosis. J Cardiovasc Electrophysiol. 2020;31(3):612–20. https://doi.org/10.1111/jce.14341.

Article  PubMed  Google Scholar 

• Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2018;72(14):e91–220. https://doi.org/10.1016/j.jacc.2017.10.054. This multisocietal guideline provides important guidance regarding indications for ICD implantation in patients with cardiac sarcoidosis. Based on these recommendations, it is reasonable to implant an ICD in patients with systolic dysfunction or significant LGE burden on CMR.

Article  PubMed  Google Scholar 

Kouranos V, Tzelepis GE, Rapti A, et al. Complementary role of CMR to conventional screening in the diagnosis and prognosis of cardiac sarcoidosis. JACC Cardiovasc Imaging. 2017;10(12):1437–47. https://doi.org/10.1016/j.jcmg.2016.11.019.

Article  PubMed  Google Scholar 

• Greulich S, Gatidis S, Gräni C, et al. Hybrid cardiac magnetic resonance/fluorodeoxyglucose positron emission tomography to differentiate active from chronic cardiac sarcoidosis. JACC Cardiovasc Imaging. 2022;15(3):445–56. https://doi.org/10.1016/j.jcmg.2021.08.018. This paper evaluated the accuracy of hybrid PET/CMR imaging for the differentiation of active from quiescent cardiac sarcoidosis. They found that hybrid imaging provided complementary information with improved detection of active disease as compared to either modality alone.

Article  PubMed  Google Scholar 

Juneau D, Nery PB, Pena E, et al. Reproducibility of cardiac magnetic resonance imaging in patients referred for the assessment of cardiac sarcoidosis; implications for clinical practice. Int J Cardiovasc Imaging. 2020;36(11):2199–207. https://doi.org/10.1007/s10554-020-01923-4.

Article  PubMed  Google Scholar 

Nordenswan HK, Pöyhönen P, Lehtonen J, et al. Incidence of sudden cardiac death and life-threatening arrhythmias in clinically manifest cardiac sarcoidosis with and without current indications for an implantable cardioverter defibrillator. Circulation. 2022; 101161CIRCULATIONAHA121058120. https://doi.org/10.1161/CIRCULATIONAHA.121.058120.